LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 57.18 | 84.90 | 1 | 6963 | 0.0001 | -0.5027 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 57.18 | 84.90 | 641 | 6963 | 0.0921 | 0.3743 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 58.88 | 84.90 | 30 | 7291 | 0.0041 | -0.1495 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 58.88 | 84.90 | 871 | 7291 | 0.1195 | 0.4368 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 58.88 | 84.90 | 1 | 7291 | 0.0001 | -0.4991 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 58.88 | 84.90 | 577 | 7291 | 0.0791 | 0.3476 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 60.59 | 84.90 | 31 | 7641 | 0.0041 | -0.1437 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 60.59 | 84.90 | 892 | 7641 | 0.1167 | 0.4366 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 60.59 | 84.90 | 1 | 7641 | 0.0001 | -0.4955 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 60.59 | 84.90 | 536 | 7641 | 0.0701 | 0.3282 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 62.29 | 84.90 | 31 | 7934 | 0.0039 | -0.1426 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 62.29 | 84.90 | 920 | 7934 | 0.1160 | 0.4391 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 62.29 | 84.90 | 1 | 7934 | 0.0001 | -0.4926 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 62.29 | 84.90 | 466 | 7934 | 0.0587 | 0.2971 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 63.99 | 84.90 | 30 | 8212 | 0.0037 | -0.1459 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 63.99 | 84.90 | 1009 | 8212 | 0.1229 | 0.4554 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 63.99 | 84.90 | 1 | 8212 | 0.0001 | -0.4900 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 63.99 | 84.90 | 424 | 8212 | 0.0516 | 0.2761 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 65.70 | 84.90 | 30 | 8484 | 0.0035 | -0.1450 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 65.70 | 84.90 | 912 | 8484 | 0.1075 | 0.4296 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 65.70 | 84.90 | 1 | 8484 | 0.0001 | -0.4876 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 65.70 | 84.90 | 365 | 8484 | 0.0430 | 0.2455 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 67.41 | 84.90 | 33 | 8766 | 0.0038 | -0.1317 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 67.41 | 84.90 | 934 | 8766 | 0.1065 | 0.4311 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 67.41 | 84.90 | 1 | 8766 | 0.0001 | -0.4852 | MN20160318_Q02 | K04 |